Author

M. Daugaard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:cell signaling & trafficking· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2

Frequent Co-Authors

B. Zhai· 3 shared C. C. Collins· 2 shared F. Ghaidi· 2 shared H. Z. Oo· 2 shared P. H. Sorensen· 2 shared S. Truong· 2 shared A. Asnacios· 1 shared A. Churg· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

B. Zhai

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Conditional CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors

N. Khazamipour, H. Z. Oo, N. Al-Nakouzi, M. Marzban, N. Khazamipour, M. E. Robert, N. Farivar, I. Moskalev, J. Lo, F. Ghaidi, I. Nelepcu, A. Moeen, S. Truong, R. Dagil, S. Choudhary, , M. Daugaard

This study develops CAR T cells specific to oncofetal chondroitin sulfate, demonstrating their ability to target and eliminate tumor cells in vitro and improve survival in vivo.

bioRxiv · May 29, 2024 · PreprintCancer Biology

A bi-functional PARP-HDAC inhibitor with activity in Ewing sarcoma

L. Ramos, S. Truong, B. Zhai, J. Joshi, F. Ghaidi, M. M. Lizardo, T. Shyp, H. Adomat, S. LeBihan, C. C. Collins, J. Bacha, D. Brown, J. Langlands, W. Shen, N. Lallous, , M. Daugaard

This paper develops a dual PARP and HDAC inhibitor, kt-3283, showing enhanced cytotoxicity and efficacy in Ewing sarcoma models compared to single-agent inhibitors.

bioRxiv · Nov 10, 2022 · PreprintCancer Biology

Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division

S. Petracchini, D. Hamaoui, A. Doye, A. Asnacios, F. Fage, E. Vitiello, m. Balland, S. Janel, F. Lafont, M. Gupta, B. Ladoux, J. Gilleron, T. M. Maia, F. Impens, L. Gagnoux, , A. Mettouchi

This study shows OPTN regulates bacterial invasion by linking HACE1-mediated Rac1 ubiquitylation to integrin mechanotransduction and ECM stiffness.

bioRxiv · Sep 19, 2021Cell Biology

Alternative polyadenylation is a determinant of oncogenic Ras function

A. Subramanian, M. Hall, H. Hou, M. Mufteev, B. Yu, K. E. Yuki, H. Nishimura, A. Sathaseevan, B. Lant, B. Zhai, J. Ellis, M. D. Wilson, M. Daugaard, W. B. Derry

This study shows that alternative polyadenylation regulates oncogenic Ras function by affecting transcript 3' UTR length in both C. elegans and human cells.

bioRxiv · Jun 8, 2020Cancer Biology

BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma

R. Shrestha, N. Nabavi, Y.-Y. Lin, F. Mo, S. Anderson, S. Volik, H. H. Adomat, D. Lin, H. Xue, X. Dong, R. Shukin, R. H. Bell, B. McConeghy, A. Haegert, S. Brahmbhatt, , C. C. Collins

The paper identifies BAP1 loss as a marker for a distinct immunogenic PeM subtype, suggesting potential therapeutic targets like immune checkpoint inhibitors.

bioRxiv · Dec 13, 2018Cancer Biology